Cyclin‐dependent kinase (CDK) inhibitors for hormone receptor‐positive advanced breast cancer

Overview of attention for article published in Cochrane database of systematic reviews, January 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 53 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 657 followers.

Check out our #Cochrane protocol - Figure 1 is free to reproduce with a RightsLink®license :) #CDK #breastcancer #palbociclib #ribociclib #abemaciclib @CochraneBCancer @cochranecollab @CochraneLibrary https://t.co/GGyXcyR0yg https://t.co/gLh7iLP3iH

Reply Repost Favourite

Cyclin-dependent kinase (CDK) inhibitors for hormone receptor-positive advanced breast cancer #CDK #breastcancer #palbociclib #ribociclib #abemaciclib @CochraneBCancer @cochranecollab @CochraneLibrary https://t.co/GGyXcyR0yg

Reply Repost Favourite

The potential of CDK inhibitors in hormone receptor-positive advanced breast cancer is now covered in a new Cochrane protocol - https://t.co/96HX4X4qve

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.